nodes	percent_of_prediction	percent_of_DWPC	metapath
Floxuridine—TYMS—Methotrexate—systemic scleroderma	0.545	1	CbGbCtD
Floxuridine—TYMP—endothelium—systemic scleroderma	0.0174	0.174	CbGeAlD
Floxuridine—TYMP—blood vessel—systemic scleroderma	0.0161	0.161	CbGeAlD
Floxuridine—TYMP—connective tissue—systemic scleroderma	0.00824	0.0824	CbGeAlD
Floxuridine—TYMP—smooth muscle tissue—systemic scleroderma	0.00754	0.0754	CbGeAlD
Floxuridine—TYMS—connective tissue—systemic scleroderma	0.00707	0.0707	CbGeAlD
Floxuridine—TYMS—smooth muscle tissue—systemic scleroderma	0.00647	0.0647	CbGeAlD
Floxuridine—TYMS—skin of body—systemic scleroderma	0.00638	0.0638	CbGeAlD
Floxuridine—TYMP—digestive system—systemic scleroderma	0.00595	0.0595	CbGeAlD
Floxuridine—TYMP—tendon—systemic scleroderma	0.00566	0.0566	CbGeAlD
Floxuridine—TYMS—digestive system—systemic scleroderma	0.00511	0.0511	CbGeAlD
Floxuridine—TYMP—lung—systemic scleroderma	0.00497	0.0497	CbGeAlD
Floxuridine—TYMS—tendon—systemic scleroderma	0.00486	0.0486	CbGeAlD
Floxuridine—TYMS—lung—systemic scleroderma	0.00426	0.0426	CbGeAlD
Floxuridine—TYMS—Clobetasol propionate—Mometasone—systemic scleroderma	0.00118	0.117	CbGdCrCtD
Floxuridine—TYMS—Flunisolide—Mometasone—systemic scleroderma	0.00116	0.115	CbGdCrCtD
Floxuridine—TYMS—Triamcinolone—Mometasone—systemic scleroderma	0.00115	0.114	CbGdCrCtD
Floxuridine—TYMS—Fluticasone Propionate—Mometasone—systemic scleroderma	0.00112	0.111	CbGdCrCtD
Floxuridine—Decreased appetite—Pentoxifylline—systemic scleroderma	0.00109	0.00317	CcSEcCtD
Floxuridine—Anaphylactic shock—Mometasone—systemic scleroderma	0.00108	0.00314	CcSEcCtD
Floxuridine—Ill-defined disorder—Captopril—systemic scleroderma	0.00108	0.00314	CcSEcCtD
Floxuridine—Photosensitivity reaction—Lisinopril—systemic scleroderma	0.00108	0.00314	CcSEcCtD
Floxuridine—Anaemia—Captopril—systemic scleroderma	0.00108	0.00313	CcSEcCtD
Floxuridine—Infection—Mometasone—systemic scleroderma	0.00108	0.00312	CcSEcCtD
Floxuridine—Gastritis—Mycophenolate mofetil—systemic scleroderma	0.00106	0.00309	CcSEcCtD
Floxuridine—Haemoglobin—Mycophenolic acid—systemic scleroderma	0.00106	0.00307	CcSEcCtD
Floxuridine—TYMS—Diflorasone—Mometasone—systemic scleroderma	0.00106	0.105	CbGdCrCtD
Floxuridine—Haemorrhage—Mycophenolic acid—systemic scleroderma	0.00105	0.00306	CcSEcCtD
Floxuridine—Malaise—Captopril—systemic scleroderma	0.00105	0.00305	CcSEcCtD
Floxuridine—Pharyngitis—Mycophenolic acid—systemic scleroderma	0.00104	0.00303	CcSEcCtD
Floxuridine—Feeling abnormal—Pentoxifylline—systemic scleroderma	0.00103	0.003	CcSEcCtD
Floxuridine—Alopecia—Azathioprine—systemic scleroderma	0.00103	0.003	CcSEcCtD
Floxuridine—Anorexia—Mometasone—systemic scleroderma	0.00103	0.003	CcSEcCtD
Floxuridine—Gastrointestinal pain—Pentoxifylline—systemic scleroderma	0.00103	0.00298	CcSEcCtD
Floxuridine—Glossitis—Methotrexate—systemic scleroderma	0.00102	0.00295	CcSEcCtD
Floxuridine—Angina pectoris—Mycophenolate mofetil—systemic scleroderma	0.00101	0.00294	CcSEcCtD
Floxuridine—Epistaxis—Lisinopril—systemic scleroderma	0.000996	0.00289	CcSEcCtD
Floxuridine—Body temperature increased—Pentoxifylline—systemic scleroderma	0.000992	0.00288	CcSEcCtD
Floxuridine—Abdominal pain—Pentoxifylline—systemic scleroderma	0.000992	0.00288	CcSEcCtD
Floxuridine—Pancytopenia—Mycophenolate mofetil—systemic scleroderma	0.000986	0.00286	CcSEcCtD
Floxuridine—Agranulocytosis—Lisinopril—systemic scleroderma	0.000986	0.00286	CcSEcCtD
Floxuridine—Discomfort—Captopril—systemic scleroderma	0.00098	0.00285	CcSEcCtD
Floxuridine—Alopecia—Leflunomide—systemic scleroderma	0.000975	0.00283	CcSEcCtD
Floxuridine—Euphoric mood—Prednisone—systemic scleroderma	0.000964	0.0028	CcSEcCtD
Floxuridine—Confusional state—Captopril—systemic scleroderma	0.000959	0.00278	CcSEcCtD
Floxuridine—Anaphylactic shock—Captopril—systemic scleroderma	0.000951	0.00276	CcSEcCtD
Floxuridine—Ill-defined disorder—Azathioprine—systemic scleroderma	0.000944	0.00274	CcSEcCtD
Floxuridine—Decreased appetite—Mometasone—systemic scleroderma	0.000942	0.00273	CcSEcCtD
Floxuridine—Pharyngitis—Lisinopril—systemic scleroderma	0.000941	0.00273	CcSEcCtD
Floxuridine—Thrombophlebitis—Prednisone—systemic scleroderma	0.00094	0.00273	CcSEcCtD
Floxuridine—Anaemia—Azathioprine—systemic scleroderma	0.00094	0.00273	CcSEcCtD
Floxuridine—Thrombocytopenia—Captopril—systemic scleroderma	0.000931	0.0027	CcSEcCtD
Floxuridine—Alopecia—Mycophenolic acid—systemic scleroderma	0.00093	0.0027	CcSEcCtD
Floxuridine—TYMS—Budesonide—Mometasone—systemic scleroderma	0.000928	0.0923	CbGdCrCtD
Floxuridine—Hypersensitivity—Pentoxifylline—systemic scleroderma	0.000925	0.00268	CcSEcCtD
Floxuridine—Muscle spasms—Leflunomide—systemic scleroderma	0.000924	0.00268	CcSEcCtD
Floxuridine—Malaise—Azathioprine—systemic scleroderma	0.000917	0.00266	CcSEcCtD
Floxuridine—Leukopenia—Azathioprine—systemic scleroderma	0.000911	0.00264	CcSEcCtD
Floxuridine—Anorexia—Captopril—systemic scleroderma	0.000907	0.00263	CcSEcCtD
Floxuridine—Stomatitis—Mycophenolate mofetil—systemic scleroderma	0.000902	0.00262	CcSEcCtD
Floxuridine—Asthenia—Pentoxifylline—systemic scleroderma	0.000901	0.00261	CcSEcCtD
Floxuridine—Ill-defined disorder—Leflunomide—systemic scleroderma	0.000891	0.00259	CcSEcCtD
Floxuridine—Anaemia—Leflunomide—systemic scleroderma	0.000888	0.00258	CcSEcCtD
Floxuridine—Gastrointestinal pain—Mometasone—systemic scleroderma	0.000886	0.00257	CcSEcCtD
Floxuridine—Muscle spasms—Mycophenolic acid—systemic scleroderma	0.000881	0.00256	CcSEcCtD
Floxuridine—Epistaxis—Mycophenolate mofetil—systemic scleroderma	0.000873	0.00253	CcSEcCtD
Floxuridine—Malaise—Leflunomide—systemic scleroderma	0.000866	0.00251	CcSEcCtD
Floxuridine—Agranulocytosis—Mycophenolate mofetil—systemic scleroderma	0.000864	0.00251	CcSEcCtD
Floxuridine—Leukopenia—Leflunomide—systemic scleroderma	0.00086	0.0025	CcSEcCtD
Floxuridine—Diarrhoea—Pentoxifylline—systemic scleroderma	0.000859	0.00249	CcSEcCtD
Floxuridine—Abdominal pain—Mometasone—systemic scleroderma	0.000856	0.00249	CcSEcCtD
Floxuridine—Body temperature increased—Mometasone—systemic scleroderma	0.000856	0.00249	CcSEcCtD
Floxuridine—Discomfort—Azathioprine—systemic scleroderma	0.000856	0.00248	CcSEcCtD
Floxuridine—Ill-defined disorder—Mycophenolic acid—systemic scleroderma	0.00085	0.00247	CcSEcCtD
Floxuridine—Anaemia—Mycophenolic acid—systemic scleroderma	0.000847	0.00246	CcSEcCtD
Floxuridine—Alopecia—Lisinopril—systemic scleroderma	0.000838	0.00243	CcSEcCtD
Floxuridine—Haemoglobin—Mycophenolate mofetil—systemic scleroderma	0.000835	0.00242	CcSEcCtD
Floxuridine—Haemorrhage—Mycophenolate mofetil—systemic scleroderma	0.000831	0.00241	CcSEcCtD
Floxuridine—Lethargy—Prednisone—systemic scleroderma	0.000831	0.00241	CcSEcCtD
Floxuridine—Decreased appetite—Captopril—systemic scleroderma	0.000827	0.0024	CcSEcCtD
Floxuridine—Malaise—Mycophenolic acid—systemic scleroderma	0.000826	0.0024	CcSEcCtD
Floxuridine—Erythema—Lisinopril—systemic scleroderma	0.000825	0.0024	CcSEcCtD
Floxuridine—Infection—Azathioprine—systemic scleroderma	0.000825	0.00239	CcSEcCtD
Floxuridine—Pharyngitis—Mycophenolate mofetil—systemic scleroderma	0.000825	0.00239	CcSEcCtD
Floxuridine—Leukopenia—Mycophenolic acid—systemic scleroderma	0.00082	0.00238	CcSEcCtD
Floxuridine—Thrombocytopenia—Azathioprine—systemic scleroderma	0.000813	0.00236	CcSEcCtD
Floxuridine—Discomfort—Leflunomide—systemic scleroderma	0.000808	0.00235	CcSEcCtD
Floxuridine—Vomiting—Pentoxifylline—systemic scleroderma	0.000798	0.00232	CcSEcCtD
Floxuridine—Muscle spasms—Lisinopril—systemic scleroderma	0.000794	0.0023	CcSEcCtD
Floxuridine—Rash—Pentoxifylline—systemic scleroderma	0.000791	0.0023	CcSEcCtD
Floxuridine—Dermatitis—Pentoxifylline—systemic scleroderma	0.000791	0.0023	CcSEcCtD
Floxuridine—Headache—Pentoxifylline—systemic scleroderma	0.000786	0.00228	CcSEcCtD
Floxuridine—Thrombophlebitis—Methotrexate—systemic scleroderma	0.000786	0.00228	CcSEcCtD
Floxuridine—Anaphylactic shock—Leflunomide—systemic scleroderma	0.000784	0.00228	CcSEcCtD
Floxuridine—Feeling abnormal—Captopril—systemic scleroderma	0.000784	0.00228	CcSEcCtD
Floxuridine—Infection—Leflunomide—systemic scleroderma	0.000779	0.00226	CcSEcCtD
Floxuridine—Gastrointestinal pain—Captopril—systemic scleroderma	0.000778	0.00226	CcSEcCtD
Floxuridine—Asthenia—Mometasone—systemic scleroderma	0.000777	0.00226	CcSEcCtD
Floxuridine—Photosensitivity—Methotrexate—systemic scleroderma	0.000775	0.00225	CcSEcCtD
Floxuridine—Discomfort—Mycophenolic acid—systemic scleroderma	0.000771	0.00224	CcSEcCtD
Floxuridine—Nervous system disorder—Leflunomide—systemic scleroderma	0.000769	0.00223	CcSEcCtD
Floxuridine—Thrombocytopenia—Leflunomide—systemic scleroderma	0.000768	0.00223	CcSEcCtD
Floxuridine—Ill-defined disorder—Lisinopril—systemic scleroderma	0.000766	0.00222	CcSEcCtD
Floxuridine—Anaemia—Lisinopril—systemic scleroderma	0.000763	0.00221	CcSEcCtD
Floxuridine—Confusional state—Mycophenolic acid—systemic scleroderma	0.000754	0.00219	CcSEcCtD
Floxuridine—Body temperature increased—Captopril—systemic scleroderma	0.000752	0.00218	CcSEcCtD
Floxuridine—Abdominal pain—Captopril—systemic scleroderma	0.000752	0.00218	CcSEcCtD
Floxuridine—Anorexia—Leflunomide—systemic scleroderma	0.000747	0.00217	CcSEcCtD
Floxuridine—Dry skin—Prednisone—systemic scleroderma	0.000746	0.00217	CcSEcCtD
Floxuridine—Nausea—Pentoxifylline—systemic scleroderma	0.000746	0.00216	CcSEcCtD
Floxuridine—Malaise—Lisinopril—systemic scleroderma	0.000744	0.00216	CcSEcCtD
Floxuridine—Infection—Mycophenolic acid—systemic scleroderma	0.000743	0.00216	CcSEcCtD
Floxuridine—Diarrhoea—Mometasone—systemic scleroderma	0.000741	0.00215	CcSEcCtD
Floxuridine—Leukopenia—Lisinopril—systemic scleroderma	0.000739	0.00215	CcSEcCtD
Floxuridine—Alopecia—Mycophenolate mofetil—systemic scleroderma	0.000734	0.00213	CcSEcCtD
Floxuridine—Nervous system disorder—Mycophenolic acid—systemic scleroderma	0.000734	0.00213	CcSEcCtD
Floxuridine—Thrombocytopenia—Mycophenolic acid—systemic scleroderma	0.000732	0.00213	CcSEcCtD
Floxuridine—Anorexia—Mycophenolic acid—systemic scleroderma	0.000713	0.00207	CcSEcCtD
Floxuridine—Muscle spasms—Mycophenolate mofetil—systemic scleroderma	0.000695	0.00202	CcSEcCtD
Floxuridine—Discomfort—Lisinopril—systemic scleroderma	0.000694	0.00202	CcSEcCtD
Floxuridine—Lethargy—Methotrexate—systemic scleroderma	0.000694	0.00202	CcSEcCtD
Floxuridine—Vomiting—Mometasone—systemic scleroderma	0.000689	0.002	CcSEcCtD
Floxuridine—Feeling abnormal—Azathioprine—systemic scleroderma	0.000684	0.00199	CcSEcCtD
Floxuridine—Rash—Mometasone—systemic scleroderma	0.000683	0.00198	CcSEcCtD
Floxuridine—Asthenia—Captopril—systemic scleroderma	0.000683	0.00198	CcSEcCtD
Floxuridine—Dermatitis—Mometasone—systemic scleroderma	0.000682	0.00198	CcSEcCtD
Floxuridine—Decreased appetite—Leflunomide—systemic scleroderma	0.000682	0.00198	CcSEcCtD
Floxuridine—Confusional state—Lisinopril—systemic scleroderma	0.000679	0.00197	CcSEcCtD
Floxuridine—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.000679	0.00197	CcSEcCtD
Floxuridine—Headache—Mometasone—systemic scleroderma	0.000679	0.00197	CcSEcCtD
Floxuridine—Anaphylactic shock—Lisinopril—systemic scleroderma	0.000674	0.00196	CcSEcCtD
Floxuridine—Ill-defined disorder—Mycophenolate mofetil—systemic scleroderma	0.000671	0.00195	CcSEcCtD
Floxuridine—Infection—Lisinopril—systemic scleroderma	0.000669	0.00194	CcSEcCtD
Floxuridine—Anaemia—Mycophenolate mofetil—systemic scleroderma	0.000668	0.00194	CcSEcCtD
Floxuridine—Thrombocytopenia—Lisinopril—systemic scleroderma	0.00066	0.00191	CcSEcCtD
Floxuridine—Body temperature increased—Azathioprine—systemic scleroderma	0.000656	0.00191	CcSEcCtD
Floxuridine—Abdominal pain—Azathioprine—systemic scleroderma	0.000656	0.00191	CcSEcCtD
Floxuridine—Malaise—Mycophenolate mofetil—systemic scleroderma	0.000652	0.00189	CcSEcCtD
Floxuridine—Diarrhoea—Captopril—systemic scleroderma	0.000651	0.00189	CcSEcCtD
Floxuridine—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.00065	0.00189	CcSEcCtD
Floxuridine—Leukopenia—Mycophenolate mofetil—systemic scleroderma	0.000647	0.00188	CcSEcCtD
Floxuridine—Feeling abnormal—Leflunomide—systemic scleroderma	0.000646	0.00188	CcSEcCtD
Floxuridine—Nausea—Mometasone—systemic scleroderma	0.000643	0.00187	CcSEcCtD
Floxuridine—Anorexia—Lisinopril—systemic scleroderma	0.000642	0.00186	CcSEcCtD
Floxuridine—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.000641	0.00186	CcSEcCtD
Floxuridine—TYMS—Clobetasol propionate—Prednisone—systemic scleroderma	0.000641	0.0637	CbGdCrCtD
Floxuridine—TYMS—Flunisolide—Prednisone—systemic scleroderma	0.000632	0.0629	CbGdCrCtD
Floxuridine—TYMS—Triamcinolone—Prednisone—systemic scleroderma	0.000626	0.0622	CbGdCrCtD
Floxuridine—Body temperature increased—Leflunomide—systemic scleroderma	0.00062	0.0018	CcSEcCtD
Floxuridine—Abdominal pain—Leflunomide—systemic scleroderma	0.00062	0.0018	CcSEcCtD
Floxuridine—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000616	0.00179	CcSEcCtD
Floxuridine—Hypersensitivity—Azathioprine—systemic scleroderma	0.000612	0.00178	CcSEcCtD
Floxuridine—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000612	0.00178	CcSEcCtD
Floxuridine—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.000608	0.00177	CcSEcCtD
Floxuridine—Vomiting—Captopril—systemic scleroderma	0.000605	0.00176	CcSEcCtD
Floxuridine—Rash—Captopril—systemic scleroderma	0.0006	0.00174	CcSEcCtD
Floxuridine—Dermatitis—Captopril—systemic scleroderma	0.000599	0.00174	CcSEcCtD
Floxuridine—Headache—Captopril—systemic scleroderma	0.000596	0.00173	CcSEcCtD
Floxuridine—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.000595	0.00173	CcSEcCtD
Floxuridine—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000591	0.00172	CcSEcCtD
Floxuridine—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000591	0.00172	CcSEcCtD
Floxuridine—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.00059	0.00171	CcSEcCtD
Floxuridine—Infection—Mycophenolate mofetil—systemic scleroderma	0.000586	0.0017	CcSEcCtD
Floxuridine—Decreased appetite—Lisinopril—systemic scleroderma	0.000586	0.0017	CcSEcCtD
Floxuridine—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.000579	0.00168	CcSEcCtD
Floxuridine—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.000578	0.00168	CcSEcCtD
Floxuridine—Hypersensitivity—Leflunomide—systemic scleroderma	0.000578	0.00168	CcSEcCtD
Floxuridine—TYMS—Diflorasone—Prednisone—systemic scleroderma	0.000577	0.0574	CbGdCrCtD
Floxuridine—Diarrhoea—Azathioprine—systemic scleroderma	0.000568	0.00165	CcSEcCtD
Floxuridine—Haemoglobin—Prednisone—systemic scleroderma	0.000566	0.00164	CcSEcCtD
Floxuridine—Nausea—Captopril—systemic scleroderma	0.000565	0.00164	CcSEcCtD
Floxuridine—Haemorrhage—Prednisone—systemic scleroderma	0.000563	0.00163	CcSEcCtD
Floxuridine—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000563	0.00163	CcSEcCtD
Floxuridine—Asthenia—Leflunomide—systemic scleroderma	0.000563	0.00163	CcSEcCtD
Floxuridine—Pancytopenia—Methotrexate—systemic scleroderma	0.000558	0.00162	CcSEcCtD
Floxuridine—Feeling abnormal—Lisinopril—systemic scleroderma	0.000555	0.00161	CcSEcCtD
Floxuridine—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000551	0.0016	CcSEcCtD
Floxuridine—Photosensitivity reaction—Methotrexate—systemic scleroderma	0.000537	0.00156	CcSEcCtD
Floxuridine—Asthenia—Mycophenolic acid—systemic scleroderma	0.000537	0.00156	CcSEcCtD
Floxuridine—Diarrhoea—Leflunomide—systemic scleroderma	0.000536	0.00156	CcSEcCtD
Floxuridine—Body temperature increased—Lisinopril—systemic scleroderma	0.000533	0.00155	CcSEcCtD
Floxuridine—Abdominal pain—Lisinopril—systemic scleroderma	0.000533	0.00155	CcSEcCtD
Floxuridine—Vomiting—Azathioprine—systemic scleroderma	0.000528	0.00153	CcSEcCtD
Floxuridine—Rash—Azathioprine—systemic scleroderma	0.000523	0.00152	CcSEcCtD
Floxuridine—Dermatitis—Azathioprine—systemic scleroderma	0.000523	0.00152	CcSEcCtD
Floxuridine—Headache—Azathioprine—systemic scleroderma	0.00052	0.00151	CcSEcCtD
Floxuridine—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000513	0.00149	CcSEcCtD
Floxuridine—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000512	0.00149	CcSEcCtD
Floxuridine—Stomatitis—Methotrexate—systemic scleroderma	0.000511	0.00148	CcSEcCtD
Floxuridine—TYMS—Budesonide—Prednisone—systemic scleroderma	0.000506	0.0503	CbGdCrCtD
Floxuridine—Vomiting—Leflunomide—systemic scleroderma	0.000499	0.00145	CcSEcCtD
Floxuridine—Alopecia—Prednisone—systemic scleroderma	0.000498	0.00144	CcSEcCtD
Floxuridine—Hypersensitivity—Lisinopril—systemic scleroderma	0.000496	0.00144	CcSEcCtD
Floxuridine—Epistaxis—Methotrexate—systemic scleroderma	0.000495	0.00144	CcSEcCtD
Floxuridine—Rash—Leflunomide—systemic scleroderma	0.000494	0.00144	CcSEcCtD
Floxuridine—Dermatitis—Leflunomide—systemic scleroderma	0.000494	0.00143	CcSEcCtD
Floxuridine—Nausea—Azathioprine—systemic scleroderma	0.000493	0.00143	CcSEcCtD
Floxuridine—Headache—Leflunomide—systemic scleroderma	0.000491	0.00143	CcSEcCtD
Floxuridine—Erythema—Prednisone—systemic scleroderma	0.00049	0.00142	CcSEcCtD
Floxuridine—Agranulocytosis—Methotrexate—systemic scleroderma	0.000489	0.00142	CcSEcCtD
Floxuridine—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000486	0.00141	CcSEcCtD
Floxuridine—TYMS—Danazol—Prednisone—systemic scleroderma	0.000485	0.0482	CbGdCrCtD
Floxuridine—Asthenia—Lisinopril—systemic scleroderma	0.000483	0.0014	CcSEcCtD
Floxuridine—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000483	0.0014	CcSEcCtD
Floxuridine—Vomiting—Mycophenolic acid—systemic scleroderma	0.000476	0.00138	CcSEcCtD
Floxuridine—Haemoglobin—Methotrexate—systemic scleroderma	0.000473	0.00137	CcSEcCtD
Floxuridine—Rash—Mycophenolic acid—systemic scleroderma	0.000472	0.00137	CcSEcCtD
Floxuridine—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000471	0.00137	CcSEcCtD
Floxuridine—Haemorrhage—Methotrexate—systemic scleroderma	0.000471	0.00137	CcSEcCtD
Floxuridine—Headache—Mycophenolic acid—systemic scleroderma	0.000469	0.00136	CcSEcCtD
Floxuridine—Pharyngitis—Methotrexate—systemic scleroderma	0.000467	0.00136	CcSEcCtD
Floxuridine—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000467	0.00135	CcSEcCtD
Floxuridine—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000467	0.00135	CcSEcCtD
Floxuridine—Nausea—Leflunomide—systemic scleroderma	0.000466	0.00135	CcSEcCtD
Floxuridine—Diarrhoea—Lisinopril—systemic scleroderma	0.000461	0.00134	CcSEcCtD
Floxuridine—Ill-defined disorder—Prednisone—systemic scleroderma	0.000455	0.00132	CcSEcCtD
Floxuridine—Anaemia—Prednisone—systemic scleroderma	0.000453	0.00132	CcSEcCtD
Floxuridine—Nausea—Mycophenolic acid—systemic scleroderma	0.000444	0.00129	CcSEcCtD
Floxuridine—Malaise—Prednisone—systemic scleroderma	0.000442	0.00128	CcSEcCtD
Floxuridine—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000435	0.00126	CcSEcCtD
Floxuridine—Vomiting—Lisinopril—systemic scleroderma	0.000428	0.00124	CcSEcCtD
Floxuridine—Rash—Lisinopril—systemic scleroderma	0.000425	0.00123	CcSEcCtD
Floxuridine—Dermatitis—Lisinopril—systemic scleroderma	0.000424	0.00123	CcSEcCtD
Floxuridine—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000424	0.00123	CcSEcCtD
Floxuridine—Headache—Lisinopril—systemic scleroderma	0.000422	0.00123	CcSEcCtD
Floxuridine—Alopecia—Methotrexate—systemic scleroderma	0.000416	0.00121	CcSEcCtD
Floxuridine—Discomfort—Prednisone—systemic scleroderma	0.000412	0.0012	CcSEcCtD
Floxuridine—Erythema—Methotrexate—systemic scleroderma	0.00041	0.00119	CcSEcCtD
Floxuridine—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000404	0.00117	CcSEcCtD
Floxuridine—Nausea—Lisinopril—systemic scleroderma	0.0004	0.00116	CcSEcCtD
Floxuridine—Anaphylactic shock—Prednisone—systemic scleroderma	0.0004	0.00116	CcSEcCtD
Floxuridine—Infection—Prednisone—systemic scleroderma	0.000398	0.00115	CcSEcCtD
Floxuridine—Nervous system disorder—Prednisone—systemic scleroderma	0.000392	0.00114	CcSEcCtD
Floxuridine—Anorexia—Prednisone—systemic scleroderma	0.000381	0.00111	CcSEcCtD
Floxuridine—Ill-defined disorder—Methotrexate—systemic scleroderma	0.00038	0.0011	CcSEcCtD
Floxuridine—Anaemia—Methotrexate—systemic scleroderma	0.000379	0.0011	CcSEcCtD
Floxuridine—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000375	0.00109	CcSEcCtD
Floxuridine—Rash—Mycophenolate mofetil—systemic scleroderma	0.000372	0.00108	CcSEcCtD
Floxuridine—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000372	0.00108	CcSEcCtD
Floxuridine—Headache—Mycophenolate mofetil—systemic scleroderma	0.00037	0.00107	CcSEcCtD
Floxuridine—Malaise—Methotrexate—systemic scleroderma	0.000369	0.00107	CcSEcCtD
Floxuridine—Leukopenia—Methotrexate—systemic scleroderma	0.000367	0.00106	CcSEcCtD
Floxuridine—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000351	0.00102	CcSEcCtD
Floxuridine—Decreased appetite—Prednisone—systemic scleroderma	0.000348	0.00101	CcSEcCtD
Floxuridine—Discomfort—Methotrexate—systemic scleroderma	0.000345	0.001	CcSEcCtD
Floxuridine—Confusional state—Methotrexate—systemic scleroderma	0.000337	0.000979	CcSEcCtD
Floxuridine—Anaphylactic shock—Methotrexate—systemic scleroderma	0.000334	0.000971	CcSEcCtD
Floxuridine—Infection—Methotrexate—systemic scleroderma	0.000332	0.000964	CcSEcCtD
Floxuridine—Feeling abnormal—Prednisone—systemic scleroderma	0.00033	0.000957	CcSEcCtD
Floxuridine—Nervous system disorder—Methotrexate—systemic scleroderma	0.000328	0.000952	CcSEcCtD
Floxuridine—Thrombocytopenia—Methotrexate—systemic scleroderma	0.000327	0.00095	CcSEcCtD
Floxuridine—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000327	0.00095	CcSEcCtD
Floxuridine—Anorexia—Methotrexate—systemic scleroderma	0.000319	0.000925	CcSEcCtD
Floxuridine—Abdominal pain—Prednisone—systemic scleroderma	0.000316	0.000918	CcSEcCtD
Floxuridine—Body temperature increased—Prednisone—systemic scleroderma	0.000316	0.000918	CcSEcCtD
Floxuridine—Hypersensitivity—Prednisone—systemic scleroderma	0.000295	0.000856	CcSEcCtD
Floxuridine—Decreased appetite—Methotrexate—systemic scleroderma	0.000291	0.000844	CcSEcCtD
Floxuridine—Asthenia—Prednisone—systemic scleroderma	0.000287	0.000833	CcSEcCtD
Floxuridine—Feeling abnormal—Methotrexate—systemic scleroderma	0.000276	0.0008	CcSEcCtD
Floxuridine—Diarrhoea—Prednisone—systemic scleroderma	0.000274	0.000795	CcSEcCtD
Floxuridine—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000273	0.000794	CcSEcCtD
Floxuridine—Abdominal pain—Methotrexate—systemic scleroderma	0.000264	0.000767	CcSEcCtD
Floxuridine—Body temperature increased—Methotrexate—systemic scleroderma	0.000264	0.000767	CcSEcCtD
Floxuridine—Vomiting—Prednisone—systemic scleroderma	0.000254	0.000739	CcSEcCtD
Floxuridine—Rash—Prednisone—systemic scleroderma	0.000252	0.000732	CcSEcCtD
Floxuridine—Dermatitis—Prednisone—systemic scleroderma	0.000252	0.000732	CcSEcCtD
Floxuridine—Headache—Prednisone—systemic scleroderma	0.000251	0.000728	CcSEcCtD
Floxuridine—Hypersensitivity—Methotrexate—systemic scleroderma	0.000246	0.000715	CcSEcCtD
Floxuridine—Asthenia—Methotrexate—systemic scleroderma	0.00024	0.000696	CcSEcCtD
Floxuridine—Nausea—Prednisone—systemic scleroderma	0.000238	0.00069	CcSEcCtD
Floxuridine—Diarrhoea—Methotrexate—systemic scleroderma	0.000229	0.000664	CcSEcCtD
Floxuridine—Vomiting—Methotrexate—systemic scleroderma	0.000213	0.000617	CcSEcCtD
Floxuridine—Rash—Methotrexate—systemic scleroderma	0.000211	0.000612	CcSEcCtD
Floxuridine—Dermatitis—Methotrexate—systemic scleroderma	0.000211	0.000612	CcSEcCtD
Floxuridine—Headache—Methotrexate—systemic scleroderma	0.000209	0.000608	CcSEcCtD
Floxuridine—Nausea—Methotrexate—systemic scleroderma	0.000199	0.000577	CcSEcCtD
